TY - JOUR AU - Lieberman, J. A. AU - Stroup, T. S. AU - McEvoy, J. P. AU - Swartz, M. S. AU - Rosenheck, R. A. AU - Perkins, D. O. AU - Keefe, R. S. AU - Davis, S. M. AU - Davis, C. E. AU - Lebowitz, B. D. AU - Severe, J. AU - Hsiao, J. K. PY - 2005 DA - 2005// TI - Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa051688 DO - 10.1056/NEJMoa051688 ID - Lieberman2005 ER - TY - JOUR AU - Nasrallah, H. A. AU - Targum, S. D. AU - Tandon, R. AU - McCombs, J. S. AU - Ross, R. PY - 2005 DA - 2005// TI - Defining and measuring clinical effectiveness in the treatment of schizophrenia JO - Psychiatr Serv VL - 56 UR - https://doi.org/10.1176/appi.ps.56.3.273 DO - 10.1176/appi.ps.56.3.273 ID - Nasrallah2005 ER - TY - JOUR PY - 2004 DA - 2004// TI - Practice guidelines for the treatment of patients with schizophrenia JO - Am J Psychiatry VL - 161 UR - https://doi.org/10.1176/appi.ajp.161.1.1 DO - 10.1176/appi.ajp.161.1.1 ID - ref3 ER - TY - JOUR AU - Burris, K. D. AU - Molski, T. F. AU - Xu, C. AU - Ryan, E. AU - Tottori, K. AU - Kikuchi, T. AU - Yocca, F. D. AU - Molinoff, P. B. PY - 2002 DA - 2002// TI - Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors JO - J Pharmacol Exp Ther VL - 302 UR - https://doi.org/10.1124/jpet.102.033175 DO - 10.1124/jpet.102.033175 ID - Burris2002 ER - TY - JOUR AU - Shapiro, D. A. AU - Renock, S. AU - Arrington, E. AU - Chiodo, L. A. AU - Liu, L. X. AU - Sibley, D. R. AU - Roth, B. L. AU - Mailman, R. PY - 2003 DA - 2003// TI - Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology JO - Neuropsychopharmacol VL - 28 UR - https://doi.org/10.1038/sj.npp.1300203 DO - 10.1038/sj.npp.1300203 ID - Shapiro2003 ER - TY - JOUR AU - Jordan, S. AU - Koprivica, V. AU - Dunn, R. AU - Tottori, K. AU - Kikuchi, T. AU - Altar, C. A. PY - 2004 DA - 2004// TI - In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function JO - Eur J Pharmacol VL - 483 UR - https://doi.org/10.1016/j.ejphar.2003.10.025 DO - 10.1016/j.ejphar.2003.10.025 ID - Jordan2004 ER - TY - JOUR AU - Jordan, S. AU - Koprivica, V. AU - Chen, R. AU - Tottori, K. AU - Kikuchi, T. AU - Altar, C. A. PY - 2002 DA - 2002// TI - The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT(1A) receptor JO - Eur J Pharmacol VL - 441 UR - https://doi.org/10.1016/S0014-2999(02)01532-7 DO - 10.1016/S0014-2999(02)01532-7 ID - Jordan2002 ER - TY - JOUR AU - Hirose, T. AU - Uwahodo, Y. AU - Yamada, S. AU - Miwa, T. AU - Kikuchi, T. AU - Kitagawa, H. AU - Burris, K. D. AU - Altar, C. A. AU - Nabeshima, T. PY - 2004 DA - 2004// TI - Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile JO - J Psychopharmacol VL - 18 UR - https://doi.org/10.1177/026988110401800308 DO - 10.1177/026988110401800308 ID - Hirose2004 ER - TY - JOUR AU - McQuade, R. D. AU - Stock, E. AU - Marcus, R. AU - Jody, D. AU - Gharbia, N. A. AU - Vanveggel, S. AU - Archibald, D. AU - Carson, W. H. PY - 2004 DA - 2004// TI - A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study JO - J Clin Psychiatry VL - 65 ID - McQuade2004 ER - TY - JOUR AU - Lieberman, J. A. PY - 2004 DA - 2004// TI - Dopamine partial agonists: a new class of antipsychotic JO - CNS Drugs VL - 18 UR - https://doi.org/10.2165/00023210-200418040-00005 DO - 10.2165/00023210-200418040-00005 ID - Lieberman2004 ER - TY - JOUR AU - Kane, J. M. AU - Carson, W. H. AU - Saha, A. R. AU - McQuade, R. D. AU - Ingenito, G. G. AU - Zimbroff, D. L. AU - Ali, M. W. PY - 2002 DA - 2002// TI - Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder JO - J Clin Psychiatry VL - 63 UR - https://doi.org/10.4088/JCP.v63n0903 DO - 10.4088/JCP.v63n0903 ID - Kane2002 ER - TY - JOUR AU - Potkin, S. G. AU - Saha, A. R. AU - Kujawa, M. J. AU - Carson, W. H. AU - Ali, M. AU - Stock, E. AU - Stringfellow, J. AU - Ingenito, G. AU - Marder, S. R. PY - 2003 DA - 2003// TI - Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder JO - Arch Gen Psychiatry VL - 60 UR - https://doi.org/10.1001/archpsyc.60.7.681 DO - 10.1001/archpsyc.60.7.681 ID - Potkin2003 ER - TY - JOUR AU - Marder, S. R. AU - McQuade, R. D. AU - Stock, E. AU - Kaplita, S. AU - Marcus, R. AU - Safferman, A. Z. AU - Saha, A. AU - Ali, M. AU - Iwamoto, T. PY - 2003 DA - 2003// TI - Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials JO - Schizophr Res VL - 61 UR - https://doi.org/10.1016/S0920-9964(03)00050-1 DO - 10.1016/S0920-9964(03)00050-1 ID - Marder2003 ER - TY - JOUR AU - McEvoy, J. AU - Daniel, D. AU - Carson, W. J. AU - McQuade, R. AU - Marcus, R. PY - 2007 DA - 2007// TI - A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia JO - J Psychiatr Res VL - 41 UR - https://doi.org/10.1016/j.jpsychires.2007.05.002 DO - 10.1016/j.jpsychires.2007.05.002 ID - McEvoy2007 ER - TY - JOUR AU - Cutler, A. AU - Marcus, R. AU - Hardy, S. AU - O'Donnell, A. AU - Carson, B. AU - McQuade, B. PY - 2006 DA - 2006// TI - The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia JO - CNS Spectrums VL - 11 ID - Cutler2006 ER - TY - JOUR AU - Kasper, S. AU - Lerman, M. N. AU - McQuade, R. D. AU - Saha, A. AU - Carson, W. H. AU - Ali, M. AU - Archibald, D. AU - Ingenito, G. AU - Marcus, R. AU - Pigott, T. PY - 2003 DA - 2003// TI - Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia JO - Int J Neuropsychopharmacol VL - 6 UR - https://doi.org/10.1017/S1461145703003651 DO - 10.1017/S1461145703003651 ID - Kasper2003 ER - TY - JOUR AU - Pigott, T. A. AU - Carson, W. H. AU - Saha, A. R. AU - Torbeyns, A. F. AU - Stock, E. G. AU - Ingenito, G. G. PY - 2003 DA - 2003// TI - Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study JO - J Clin Psychiatry VL - 64 UR - https://doi.org/10.4088/JCP.v64n0910 DO - 10.4088/JCP.v64n0910 ID - Pigott2003 ER - TY - CHAP AU - Guy, W. PY - 1976 DA - 1976// TI - Clinical Global Impressions (CGI) BT - ECDEU Assessment Manual for Psychopharmacology US Department of Health, Education, and Welfare Publication (ADM) 76-338 PB - National Institute of Mental Health CY - Rockville, MD ID - Guy1976 ER - TY - JOUR AU - Overall, J. E. AU - Gorham, D. R. PY - 1962 DA - 1962// TI - The Brief Psychiatric Rating Scale JO - Psychol Rep VL - 10 UR - https://doi.org/10.2466/pr0.1962.10.3.799 DO - 10.2466/pr0.1962.10.3.799 ID - Overall1962 ER - TY - BOOK PY - 1993 DA - 1993// TI - WHOQoL Study Protocol. WHO (MNH7PSF/93.9) PB - WHO CY - Geneva, Switzerland ID - ref20 ER - TY - JOUR AU - Tandon, R. AU - Marcus, R. N. AU - Stock, E. G. AU - Riera, L. C. AU - Kostic, D. AU - Pans, M. AU - McQuade, R. D. AU - Nyilas, M. AU - Iwamoto, T. AU - Crandall, D. T. PY - 2006 DA - 2006// TI - A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA) JO - Schizophr Res VL - 84 UR - https://doi.org/10.1016/j.schres.2005.12.857 DO - 10.1016/j.schres.2005.12.857 ID - Tandon2006 ER - TY - JOUR AU - Lindstrom, E. AU - Bingefors, K. PY - 2000 DA - 2000// TI - Patient compliance with drug therapy in schizophrenia. Economic and clinical issues JO - Pharmacoeconomics VL - 18 ID - Lindstrom2000 ER - TY - JOUR AU - Fleischhacker, W. W. AU - McQuade, R. D. AU - Marcus, R. N. AU - Archibald, D. AU - Swanink, R. AU - Carson, W. H. PY - 2009 DA - 2009// TI - A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia JO - Biol Psychiatry VL - 65 UR - https://doi.org/10.1016/j.biopsych.2008.07.033 DO - 10.1016/j.biopsych.2008.07.033 ID - Fleischhacker2009 ER - TY - JOUR AU - Wolf, J. AU - Janssen, F. AU - Lublin, H. AU - Salokangas, R. K. AU - Allain, H. AU - Smeraldi, E. AU - Bernardo, M. AU - Millar, H. AU - Pans, M. AU - Adelbrecht, C. AU - Laughton, J. AU - Werner, C. AU - Maier, W. PY - 2007 DA - 2007// TI - A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA) JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X225448 DO - 10.1185/030079907X225448 ID - Wolf2007 ER - TY - JOUR AU - Kerwin, R. AU - Millet, B. AU - Herman, E. AU - Banki, C. M. AU - Lublin, H. AU - Pans, M. AU - Hanssens, L. AU - L'Italien, G. AU - McQuade, R. D. AU - Beuzen, J. N. PY - 2007 DA - 2007// TI - A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripiprazole: (STAR) study JO - Eur Psychiatry VL - 22 UR - https://doi.org/10.1016/j.eurpsy.2007.03.002 DO - 10.1016/j.eurpsy.2007.03.002 ID - Kerwin2007 ER - TY - JOUR PY - 2004 DA - 2004// TI - Consensus development conference on antipsychotic drugs and obesity and diabetes. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.2.596 DO - 10.2337/diacare.27.2.596 ID - ref26 ER - TY - JOUR AU - Newcomer, J. W. PY - 2005 DA - 2005// TI - Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review JO - CNS Drugs VL - 19 ID - Newcomer2005 ER - TY - JOUR AU - De Hert, M. AU - Hanssens, L. AU - van Winkel, R. AU - Wampers, M. AU - Van Eyck, D. AU - Scheen, A. AU - Peuskens, J. PY - 2007 DA - 2007// TI - A case series: evaluation of the metabolic safety of aripiprazole JO - Schizophr Bull VL - 33 UR - https://doi.org/10.1093/schbul/sbl037 DO - 10.1093/schbul/sbl037 ID - De Hert2007 ER - TY - JOUR AU - Byerly, M. AU - Suppes, T. AU - Tran, Q. V. AU - Baker, R. A. PY - 2007 DA - 2007// TI - Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives JO - J Clin Psychopharmacol VL - 27 UR - https://doi.org/10.1097/jcp.0b013e31815ac4e5 DO - 10.1097/jcp.0b013e31815ac4e5 ID - Byerly2007 ER - TY - JOUR AU - Bai, Y. M. AU - Ting Chen, T. AU - Chen, J. Y. AU - Chang, W. H. AU - Wu, B. AU - Hung, C. H. AU - Kuo Lin, W. PY - 2007 DA - 2007// TI - Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study JO - J Clin Psychiatry VL - 68 UR - https://doi.org/10.4088/JCP.v68n0808 DO - 10.4088/JCP.v68n0808 ID - Bai2007 ER -